| Peripheral Nerve Disorders | Lifetime | 2 | US 2 | 99.85 |
| Hereditary Neurological Disorders | Lifetime | 3 | US 2 | 99.65 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 15 | US 6 | 99.83 |
| Peripheral Neuropathies and Disorders | Lifetime | 19 | US 7 | 99.73 |
| Pain Mechanisms and Treatments | Lifetime | 39 | US 24 | 99.70 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 26 | US 17 | 99.39 |
| Neurological and metabolic disorders | Lifetime | 17 | US 8 | 99.27 |
| Dermatological and Skeletal Disorders | Lifetime | 39 | US 19 | 98.74 |
| Myasthenia Gravis and Thymoma | Lifetime | 111 | US 38 | 98.01 |
| Nerve Injury and Rehabilitation | Lifetime | 144 | US 92 | 98.42 |
| Nerve injury and regeneration | Lifetime | 259 | US 122 | 98.28 |
| Genetic Neurodegenerative Diseases | Lifetime | 494 | US 193 | 97.38 |
| Neurological diseases and metabolism | Lifetime | 218 | US 82 | 97.18 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 966 | US 330 | 97.15 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 362 | US 202 | 96.35 |
| Vasculitis and related conditions | Lifetime | 458 | US 126 | 96.04 |
| Skin and Cellular Biology Research | Lifetime | 509 | US 200 | 94.17 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 873 | US 262 | 92.80 |
| Spinal Hematomas and Complications | Lifetime | 258 | US 146 | 92.96 |
| Caveolin-1 and cellular processes | Lifetime | 420 | US 194 | 90.16 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 573 | US 142 | 87.84 |
| Neurology and Historical Studies | Lifetime | 506 | US 222 | 85.41 |
| Immunotoxicology and immune responses | Lifetime | 625 | US 314 | 77.33 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 520 | US 103 | 87.19 |
| Peripheral Nerve Disorders | 2021-2025 | 251 | US 88 | 82.23 |
| Hereditary Neurological Disorders | 2021-2025 | 226 | US 38 | 81.64 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 760 | US 250 | 79.16 |
| Neurological and metabolic disorders | 2021-2025 | 471 | US 105 | 53.92 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 652 | US 277 | 47.83 |